Earnings Summary

Jazz Pharmaceuticals Plc’s revenue jumped 2.62% since last year same period to $957.32Mn in the Q2 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 7.22% jump in its revenue since last 3-months.

Jazz Pharmaceuticals Plc’s net profit jumped 201.28% since last year same period to $104.44Mn in the Q2 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 50.44% jump in its net profits since last 3-months.

Jazz Pharmaceuticals Plc’s net profit margin jumped 193.59% since last year same period to 10.91% in the Q2 2023. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 40.31% jump in its net profit margins since last 3-months.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 4.54 - a -1.52% fall from last quarter’s estimates.

Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 4.54.

Jazz Pharmaceuticals Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Jazz Pharmaceuticals Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.